Inactive Instrument

Highlights Wuhan General Group (China), Inc. Other OTC

Equities

Institute of Biomedical Research Corp. agreed to acquire Biomedical and Nutraceutical Assets of Wuhan General Group, Inc. (OTCPK : WUHN).	22-07-17	CI
Wuhan General Group, Inc. reached an agreement to acquire a 40% stake in Tsime Pharmaceuticals Ltd from Bataung Likate and other shareholders.	21-12-07	CI
Wuhan to Launch CBD Cosmetics and CBD Infused Coffee in South Africa	19-11-07	CI
Wuhan General Group, Inc. Expands Capacity to Produce Medicinal Marijuana and Mushrooms	19-05-17	CI
Wuhan General Group, Inc. Provides Revenue Guidance for the Second Quarter, Third Quarter and Fourth Quarter of 2019	19-03-28	CI
EPlay and Wuhan Announce Strategic Partnership to Create New Medical Cannabis App	18-10-04	CI
Wuhan General Group, Inc. signed a non-binding Letter of Intent to acquire MJ MedTech Inc.	18-10-03	CI
Wuhan General Group shares more information on Spin-Off	18-09-05	GL
Wuhan General Group Seeks To Potential Acquisition	18-09-05	CI
Wuhan General Group Announces Intention to Spin-off Company's Tech Development Business	18-09-04	GL
The Board of Wuhan General Group, Inc. announced the spin-off of Strategic Development of Technology, Inc.	18-09-03	CI
USA Real Estate Holding Company & Wuhan General Group, Inc. Signs Letter of Intent to Launch Bitcoin & Cryptocurrency Mining Operations	18-06-19	CI
The Company announces that it has finalized the merger with Wuhan General Group (China), Inc. as part of a Reverse Take-Over or "RTO"	18-02-22	GL

No results for this search